#DNAvaccine
LightNews LightNews
onclive.bsky.social
PTVG-HP DNA vaccine demonstrated an overall survival benefit vs placebo in patients with PSA-recurrent prostate cancer. 📊✨
Read more ➡️ www.onclive.com/view/ptvg-hp...
#ProstateCancer #GUonc #CancerVaccines #Immunotherapy #DNAvaccine #PrecisionOncology #Oncology
pTVG-HP DNA Vaccine Extends Overall Survival vs Placebo in PSA-Recurrent Prostate Cancer | OncLive
Long-term follow-up showed pTVG-HP nearly doubled median OS compared with placebo in biochemically recurrent prostate cancer.
www.onclive.com
August 20, 2026 at 9:07 PM
erinha-ri.bsky.social
🧫 Can a DNA vaccine stop Klebsiella?

At Univ. of Girona, López Siles’ team is developing KlebsiGene to prevent drug-resistant infections.
With ISIDORe/EATRIS, they confirmed no DNA integration & began transcriptome analysis.

#ISIDORe #Klebsiella #DNAVaccine #AMR #VaccineDevelopment
June 7, 2025 at 3:59 PM
erinha-ri.bsky.social
🧫 KlebsiGene: a DNA vaccine against Klebsiella.

López Siles (Univ. of Girona) advanced regulatory strategy & safety validation with ISIDORe, EATRIS & FIMM.

✔️ TPP defined
✔️ No DNA integration
✔️ Transcriptomics ongoing
#ISIDORe #DNAVaccine #AMR #Klebsiella #VaccineDevelopment
June 4, 2025 at 1:59 PM
njmicrobe.bsky.social
Can DNA vaccines overcome the cold-chain and reactogenicity problems of mRNA? Imunon’s PlaCCine platform just might. Strong T-cell immunity, easy delivery, and protection against Omicron in animal models. go.njmicrobe.org/EXvoFy #DNAVaccine #Imunon #COVID19 #GlobalHealth #NJBiotech
A New Era for DNA Vaccines? Imunon’s PlaCCine DNA Platform
The global response to the COVID-19 pandemic highlighted the incredible power of nucleic acid vaccines, particularly the rapid development and deployment of mRNA vaccines. However, it also brought to ...
go.njmicrobe.org
July 29, 2025 at 12:34 AM
sigtrans-sttt.bsky.social
Replication-competent vaccinia Tiantan-based #HIV candidate vaccine combined with a #DNAvaccine component exhibits promising safety & tolerability profiles while eliciting a robust #ImmuneResponse against #HIVantigens. #medsky

#STTT #OpenAccess: doi.org/10.1038/s413...
Safety and immunogenicity of an HIV vaccine trial with DNA prime and replicating vaccinia boost - Signal Transduction and Targeted Therapy
Signal Transduction and Targeted Therapy - Safety and immunogenicity of an HIV vaccine trial with DNA prime and replicating vaccinia boost
doi.org
August 21, 2025 at 12:15 PM